Submit Content
Sponsored in Part By
Sponsored
Lung Cancer - Radiation Therapy
Thoracic
Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: Post hoc analysis dressed up as level-1 evidence? – Part 3 of 9
By Lisa Brown
Aug. 20, 2015
0
Surgery versus SABR for resectable non-small-cell lung cancer – Part 4 of 9
By Lisa Brown
Aug. 20, 2015
0
Thoracic
Surgery versus SABR for resectable non-small-cell lung cancer – Part 5 of 9
By Lisa Brown
Aug. 20, 2015
0
Thoracic
Surgery versus SABR for resectable non-small-cell lung cancer – Part 6 of 9
By Lisa Brown
Aug. 20, 2015
0
Thoracic
Surgery versus SABR for resectable non-small-cell lung cancer – Part 7 of 9
By Lisa Brown
Aug. 20, 2015
0
Thoracic
Surgery versus SABR for resectable non-small-cell lung cancer – Part 8 of 9
By Lisa Brown
Aug. 20, 2015
0
Thoracic
Surgery versus SABR for resectable non-small-cell lung cancer – Authors’ reply – Part 9 of 9
By Lisa Brown
Aug. 20, 2015
0
Thoracic
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
By Mark Ferguson
May. 20, 2015
0
Thoracic
Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Radiotherapy for Stage I Lung Cancer
By Mark Ferguson
Apr. 2, 2015
0
Thoracic
Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated with Adjuvant Chemotherapy: A Review of the National Cancer Data Base
By Lisa Brown
Mar. 10, 2015
0
Thoracic
Postoperative Radiotherapy is Associated with Better Survival in Non–Small Cell Lung Cancer with Involved N2 Lymph Nodes: Results of an Analysis of the National Cancer Data Base
By Mark Ferguson
Feb. 21, 2015
0
Thoracic
Pulmonary Neuroendocrine (Carcinoid) Tumors: European Neuroendocrine Tumor Society Expert Consensus and Recommendations for Best Practice for Typical and Atypical Pulmonary Carcinoid
By Mark Ferguson
Feb. 3, 2015
0
1 2 3 4

Log In

New to CTSNet? Sign Up

Forgot Password